<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In fact, the gut microbiota has been suggested as a therapeutic target in various diseases, including obesity and diabetes [
 <xref rid="pone.0218490.ref014" ref-type="bibr" class="xref">14</xref>]. Currently, most efforts are focused on fecal microbiota transplantation with encouraging results [
 <xref rid="pone.0218490.ref015" ref-type="bibr" class="xref">15</xref>]. Nonetheless, concerns have been raised regarding its safety both at the biological and operative levels [
 <xref rid="pone.0218490.ref016" ref-type="bibr" class="xref">16</xref>]. Moreover, the inconsistency in fecal microbiota compositions among donors as well as differences in the procedures are an unavoidable issue [
 <xref rid="pone.0218490.ref017" ref-type="bibr" class="xref">17</xref>], in addition to the unregulated state of fecal microbiota transplantation, outside the approved clinical practice [
 <xref rid="pone.0218490.ref018" ref-type="bibr" class="xref">18</xref>]. Thus, a simpler and measurable approach, e.g., using food or chemical compounds that are effective and safe for regulating the gut microbiota is desirable.
</p>
